Stay updated on Atezolizumab Combo in Untreated BRAFv600+ Melanoma Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab Combo in Untreated BRAFv600+ Melanoma Clinical Trial page.

Latest updates to the Atezolizumab Combo in Untreated BRAFv600+ Melanoma Clinical Trial page
- Check5 days agoChange DetectedA new revision entry v3.3.3 was added to the history, and the HHS Vulnerability Disclosure and revision v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedOnly a minor site revision update was made (Revision: v3.3.2 added and Revision: v3.2.0 removed), with no changes to the study record history or its contents. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedThe funding-lapse warning on the page was removed. The page no longer displays the prior disclaimer that updates may be delayed due to appropriations.SummaryDifference0.4%

- Check55 days agoChange DetectedA new version was posted in the study record history, updating the Study Status and Recruitment Status sections. Related details such as Contacts/Locations and Outcome Measures may also have been updated.SummaryDifference0.1%

- Check84 days agoChange Detected- Updated the page to v3.2.0 and added a government-operational status notice clarifying potential delays and open status of NIH Clinical Center. - Removed the previous version tag v3.1.0.SummaryDifference9%

- Check91 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new version is available.SummaryDifference0.2%

Stay in the know with updates to Atezolizumab Combo in Untreated BRAFv600+ Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab Combo in Untreated BRAFv600+ Melanoma Clinical Trial page.